NYSE · PPG

PPG Industries, Inc.

$118.47 +$2.47 (+2.13%) 1D After hours

Key Metrics

$25.86B
Market cap
16.31×
P/E · TTM
$16.12B
Revenue · TTM
$1.59B
Net income
EPS · TTM $6.92
Dividend yield 2.4%
Free cash flow $1.23B
Beta · 1Y 0.99
EBITDA · TTM $2.48B
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 8
    The stock moved +8.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 8
  • Mar 20
    From its Feb 12 high, the share price fell 26%.

    Peak close $131.56 on Feb 12; trough close $97.22 on Mar 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -26%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$25.86B
Enterprise value$31.03B
Shares outstanding222.9M
52-wk range$93.39 – $133.43
Avg volume · 20D1.6M
Net cash −$5.17B
Book value / share$35.40
IndustryPaints, Varnishes, Lacquers, Enamels & Allied Prods
ExchangeNYSE
About PPG Industries, Inc.
IPO dateDec 17, 1945
Employees43500

PPG is the world's second-largest producer of paints and coatings. PPG's products are sold to a wide variety of end users, including industrial segments such as automotive, aerospace, and protective and marine, as well as paint contractors and do-it-yourself customers.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E16.31
P/S1.60
P/FCF21.07
EV/EBITDA12.52
EV/Sales1.92
Graham №$74.27

Profitability

Gross
Operating 12.8%
Net 9.8%
FCF 7.6%
ROE / ROIC 21.3% · 11.7%

Financial Health

Current ratio1.61
Quick ratio1.17
Debt / equity0.88
Debt / EBITDA 2.88
Net cash −$5.17B
Working capital$3.02B

Cash Flow · TTM

Operating CF $1.99B
Capex −$765.00M
Free cash flow $1.23B
Buybacks $492.00M
Dividends paid $633.00M
Shareholder yield 4.4%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

3.8
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$74.27 vs $118.47
Trades 1.6× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings